This article was originally published in The Gray Sheet
Executive SummaryCompany President Elizabeth Davila named CEO, effective Feb. 13. Outgoing CEO Mark Logan will remain board chairman until firm's next annual meeting. Separately, Federal Trade Commission drops suit against Visx following Patent and Trademark Office's issuance of a reexamination certificate for Visx's '388 patent. FTC had appealed a June 1999 FTC administrative law judge dismissal of the patent fraud complaint (1"The Gray Sheet" June 28, 1999, In Brief)
You may also be interested in...
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.